ABOVE: Sarepta research associate Kaitlin Adegboye stains muscle cryosections for analysis.
© SAREPTA THERAPEUTICS
Sarepta Therapeutics’s outpost in Ohio occupies a collection of offices and labs on the second floor of a large, squat structure known as “Building 4” in a business park outside of Columbus. Despite the facility’s unassuming exterior, the start of research onsite here in spring 2019 marked a milestone in Ohio’s two-decade-long march toward becoming a gene therapy hub. “We’re making a very significant commitment and investment in Columbus,” Doug Ingram, the CEO of Cambridge, Massachusetts–based Sarepta, told Columbus Business First in an article about the new division. “There is a real chance Columbus, Ohio, could become the most important place in the world for gene therapy development.”
We’ve helped prove the concept that gene therapy can actually go from bench to bedside.
With its Ohio research center, Sarepta joins a local gene therapy ecosystem. Bolstered by ...
